Click Here to return To Results

 

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke:The ECASS JAMA 274:1017-1025, 10581995., Hacke,W.,et al, 1995 See this aricle in Pubmed Article Abstract Intravenous thrombolysis in acute ischemic stroke is effective in improving some functional measures and neurologic outcome in a defined subgroup of stroke patients with moderate to severe neurologic deficit and without extended infarct signs on the initial CT scan.However,the identification of this subgroup is difficult and depends on recognition of early major CT signs of early infarction.Therefore,since treating ineligible patients is associated with an unacceptable increase of hemorrhagic complications and death,intravenous thrombolysis cannot currently be recommended for use in an unselected population of acute ischemic stroke patients.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction CAT scan CAT scan,early changes in CVA cerebral ischemia cerebrovascular accident cerebrovascular accident,acute management of cerebrovascular accident,thrombolytic agents in treatment fibrinolytic agents fibrinolytic agents,complications intracerebral hemorrhage tissue plasminogen activator,intravenous

Click Here to return To Results